Advertisement
Screener

PRECISION BIOSCIENCES INC (DTIL) Form D

PRECISION BIOSCIENCES INC Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2018-06-08: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-05-25; Total offering amount $110,000,000.
  • 2015-05-12: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-04-30; Total offering amount $25,650,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2018-06-08Rule 506(b)Equity2018-05-25$110,000,000$88,075,013$21,924,98740
2015-05-12Rule 506(b)Equity2015-04-30$25,650,000$25,650,000$011

Similar stocks

Stock NameCountryMarket CapPE Ratio
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Alector, Inc. (ALEC)United States$0.213B-1.90